Transaction · 0001628280-26-034106

Autor Deborah M.

Autor Deborah M., DIR, reported an open-market or private sale at Amneal Pharmaceuticals, Inc. involving 34819.000000 shares for an estimated $450557.86. Reported holdings after the transaction were 93660.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
AMRXAmneal Pharmaceuticals, Inc.
Trade date
May 11, 2026
Filing date
May 12, 2026
View on SEC Insider profile
Disclosed value-$450kShares × reported price
Shares traded34.8k$12.94 per share
Holdings after93.6kDirect
% of reported position traded27.1%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 128,479 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

AMRX price since this filing

Daily closing prices, with the filing date and available return windows
AMRX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-034106
Class A Common Stock
Transaction date
May 11, 2026
Filed May 12, 2026, 08:10 PM · 1d delay
Shares
34,819 sh
$12.94 per share
Estimated value
-$450k
Computed from shares × price
Holdings after
93,660 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.75 to $13.27 per share, inclusive. The Reporting Person

  2. undertakes to provide Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price

  3. within the ranges set forth in this footnote.

Original filing · 0001628280-26-034106
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

AMRX